nach oben

Erschienen in:

08.04.2017 | Original Article

Postmortem genetic testing should be recommended in sudden cardiac death cases due to thoracic aortic dissection

verfasst von: Marina Gago-Díaz, Eva Ramos-Luis, Silvia Zoppis, Esther Zorio, Pilar Molina, Aitana Braza-Boïls, Juan Giner, Beatriz Sobrino, Jorge Amigo, Alejandro Blanco-Verea, Ángel Carracedo, María Brion

Erschienen in: International Journal of Legal Medicine | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Acute thoracic aortic dissections and ruptures, the main life-threatening complications of the corresponding aneurysms, are an important cause of sudden cardiac death. Despite the usefulness of the molecular diagnosis of these conditions in the clinical setting, the corresponding forensic field remains largely unexplored. The main goal of this study was to explore and validate a new massive parallel sequencing candidate gene assay as a diagnostic tool for acute thoracic aortic dissection autopsy cases.

Materials and methods

Massive parallel sequencing of 22 thoracic aortic disease candidate genes performed in 17 cases of thoracic aortic dissection using AmpliSeq and Ion Proton technologies. Genetic variants were filtered by location, type, and frequency at the Exome Aggregation Consortium and an internal database and further classified based on the American College of Medical Genetics and Genomics (ACMG) recommendations published in 2015. All prioritized results were confirmed by traditional sequencing.

Results

From the total of 10 potentially pathogenic genetic variants identified in 7 out of the 17 initial samples, 2 of them were further classified as pathogenic, 2 as likely pathogenic, 1 as possibly benign, and the remaining 5 as variants of uncertain significance, reaching a molecular autopsy yield of 23%, approximately.

Conclusions

This massive parallel sequencing candidate gene approach proved useful for the molecular autopsy of aortic dissection sudden cardiac death cases and should therefore be progressively incorporated into the forensic field, being especially beneficial for the anticipated diagnosis and risk stratification of any other family member at risk of developing the same condition.

Nur mit Berechtigung zugänglich

Montagnana M, Lippi G, Franchini M, Banfi G, Guidi G (2008) Sudden cardiac death in young athletes. Intern Med 47(15):1373–1378CrossRefPubMed

Ripperger T, Tröger H, Schmidtke J (2009) The genetic message of a sudden, unexpected death due to thoracic aortic dissection. Forensic Sci Int 187(1–3):1–5. doi:10.1016/j.forsciint.2009.01.020 CrossRefPubMed

Kuzmik G, Sang A, Elefteriades J (2012) Natural history of thoracic aortic aneurysms. J Vasc Surg 56(2):565–571. doi:10.1016/j.jvs.2012.04.053 CrossRefPubMed

Prakash S, Kuang S, Investigators GTACR, Regalado E, Guo D, Milewicz D (2016) Recurrent rare genomic copy number variants and bicuspid aortic valve are enriched in early onset thoracic aortic aneurysms and dissections. PLoS One 11(4):e0153543. doi:10.1371/journal.pone.0153543 CrossRefPubMedPubMedCentral

Elefteriades J (2008) Thoracic aortic aneurysm: reading the enemy’s playbook. Yale J Biol Med 81(4):175–186PubMedPubMedCentral

Pannu H, Tran-Fadulu V, Milewicz D (2005) Genetic basis of thoracic aortic aneurysms and aortic dissections. Am Mournal Med Genet Part C 139C(1):10–16. doi:10.1002/ajmg.c.30069 CrossRef

Erbel R, Aboyans V, Boileau C, Bossone E, Di Bartolomeo R, Eggebrecht H et al (2014) ESC guidelines on the diagnosis and treatment of aortic diseases. Eur Heart J 35(41):2873–2926. doi:10.1093/eurheartj/ehu281 CrossRefPubMed

Milewicz DM, Guo D-C, Tran-Fadulu V, Lafont AL, Papke CL, Inamoto S et al (2008) Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction. Annu Rev Genomics Hum Genet 9:283–302. doi:10.1146/annurev.genom.8.080706.092303 CrossRefPubMed

Cannon Albright L, Camp N, Farnham J, MacDonald J, Abtin K, Rowe KG (2003) A genealogical assessment of heritable predisposition to aneurysms. J Neurosurg 99(4):637–643. doi:10.3171/jns.2003.99.4.0637 CrossRefPubMed

10.

Isselbacher E (2005) Thoracic and abdominal aortic aneurysms. Circulation 111(6):816–828. doi:10.1161/01.CIR.0000154569.08857.7A CrossRefPubMed

11.

Li Y, Li L, Mu H, Fan S, He F, Wang Z (2015) Aortic dissection and sudden unexpected deaths: a retrospective study of 31 forensic autopsy cases. J Forensic Sci 60(5):1206–1211. doi:10.1111/1556-4029.12768 CrossRefPubMed

12.

Bisleri G, Bagozzi L, Muneretto C (2013) Current evidence and insights about genetics in thoracic aorta disease. Sci World J 2013:e962097. doi:10.1155/2013/962097 CrossRef

13.

Coady MA, Davies RR, Roberts M, Goldstein LJ, Rogalski MJ, Rizzo JA et al (1999) Familial patterns of thoracic aortic aneurysms. Arch Surg 134(4):361–367CrossRefPubMed

14.

Poninska J, Bilinska Z, Franaszczyk M, Michalak E, Rydzanicz M, Szpakowski E et al (2016) Next-generation sequencing for diagnosis of thoracic aortic aneurysms and dissections: diagnostic yield, novel mutations and genotype phenotype correlations. J Transl Med 14(1):115. doi:10.1186/s12967-016-0870-4 CrossRefPubMedPubMedCentral

15.

Gillis E, Van Laer L, Loeys B (2013) Genetics of thoracic aortic aneurysm: at the crossroad of transforming growth factor-β signaling and vascular smooth muscle cell contractility. Circ Res 113(3):327–340. doi:10.1161/CIRCRESAHA.113.300675 CrossRefPubMed

16.

Bowdin S, Laberge A, Verstraeten A, Loeys B (2016) Genetic testing in thoracic aortic disease-when, why, and how? Can J Cardiol 32(1):131–134. doi:10.1016/j.cjca.2015.09.018 CrossRefPubMed

17.

Campens L, Renard M, Callewaert B, Coucke P, De Backer J, De Paepe A (2013) New insights into the molecular diagnosis and management of heritable thoracic aortic aneurysms and dissections. Pol Arch Med Wewn 123(12):693–700PubMed

18.

Hannuksela M, Stattin E, Nyberg P, Carlberg B (2014) Familial thoracic aortic aneurysms and dissections can be divided into three different main categories. Lakartidningen 111(9–10):399–403PubMed

19.

Saratzis A, Bown M (2014) The genetic basis for aortic aneurysmal disease. Heart 100(12):916–922. doi:10.1136/heartjnl-2013-305130 CrossRefPubMed

20.

Halushka M, Angelini A, Bartoloni G, Basso C, Batoroeva L, Bruneval P et al (2016) Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology: II. Noninflammatory degenerative diseases—nomenclature and diagnostic criteria. Cardiovasc Pathol 25(3):247–257. doi:10.1016/j.carpath.2016.03.002 CrossRefPubMed

21.

Hasham S, Lewin M, Tran V, Pannu H, Muilenburg A, Willing M et al (2004) Nonsyndromic genetic predisposition to aortic dissection: a newly recognized, diagnosable, and preventable occurrence in families. Ann Emerg Med 43(1):79–82. doi:10.1016/S0196064403008187 CrossRefPubMed

22.

Guo D, Hasham S, Kuang S, Vaughan C, Boerwinkle E, Chen H et al (2001) Familial thoracic aortic aneurysms and dissections: genetic heterogeneity with a major locus mapping to 5q13-14. Circulation 103(20):2461–2468CrossRefPubMed

23.

Jondeau G, Boileau C (2012) Genetics of thoracic aortic aneurysms. Curr Atheroscler Rep 14(3):219–226. doi:10.1007/s11883-012-0241-4 CrossRefPubMed

24.

Andelfinger G, Loeys B, Dietz H (2016) A decade of discovery in the genetic understanding of thoracic aortic disease. Can J Cardiol 32(1):13–25. doi:10.1016/j.cjca.2015.10.017 CrossRefPubMed

25.

Wooderchak-Donahue W, Vansant-Webb C, Tvrdik T, Plant P, Lewis T, Stocks J et al (2015) Clinical utility of a next generation sequencing panel assay for Marfan and Marfan-like syndromes featuring aortopathy. Am J Med Genet Part A 167A(8):1747–1757. doi:10.1002/ajmg.a.37085 CrossRefPubMed

26.

Braverman AC (2015) Heritable thoracic aortic aneurysm disease. Recognizing phenotypes, exploring genotypes. J Am Coll Cardiol 65(13):1337–1339. doi:10.1016/j.jacc.2014.12.056 CrossRefPubMed

27.

Arslan-Kirchner M, Arbustini E, Boileau C, Charron P, Child A, Collod-Beroud G et al (2016) Clinical utility gene card for: hereditary thoracic aortic aneurysm and dissection including next-generation sequencing-based approaches. Eur J Hum Genet 24(1):e1–e5. doi:10.1038/ejhg.2015.225 CrossRefPubMed

28.

Hiratzka L, Bakris G, Beckman J, Bersin R, Carr V, Casey D et al (2010) 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. J Am Coll Cardiol 55(14):e27–129. doi:10.1016/j.jacc.2010.02.015 CrossRefPubMed

29.

Klintschar M, Bilkenroth U, Arslan-Kirchner M, Schmidtke J, Stiller D (2009) Marfan syndrome: clinical consequences resulting from a medicolegal autopsy of a case of sudden death due to aortic rupture. Int J Legal Med 123(1):55–58. doi:10.1007/s00414-008-0288-5 CrossRefPubMed

30.

Proost D, Vandeweyer G, Meester J, Salemink S, Kempers M, Ingram C et al (2015) Performant mutation identification using targeted next-generation sequencing of 14 thoracic aortic aneurysm genes. Hum Mutat 36(8):808–814. doi:10.1002/humu.22802 CrossRefPubMed

31.

Hirschhorn JN, Daly MJ (2005) Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6(2):95–108. doi:10.1038/nrg1521 CrossRefPubMed

32.

Brion M, Sobrino B, Martinez M, Blanco-Verea A, Carracedo A (2015) Massive parallel sequencing applied to the molecular autopsy in sudden cardiac death in the young. Forensic Sci Int Genet 18:160–170. doi:10.1016/j.fsigen.2015.07.010 CrossRefPubMed

33.

Yang H, Wang K (2015) Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR. Nat Protoc 10(10):1556–1566. doi:10.1038/nprot.2015.105 CrossRefPubMedPubMedCentral

34.

Exome Aggregation Consortium (ExAC), available from exac.broadinstitute.org/, and accessed [2016 Oct 10]

35.

Robinson J, Thorvaldsdóttir H, Winckler W, Guttman M, Lander E, Getz G et al (2011) Integrative Genomics Viewer. Nat Biotechnol 29(1):24–26. doi:10.1038/nbt.1754 CrossRefPubMedPubMedCentral

36.

Thorvaldsdóttir H, Robinson J, Mesirov J (2013) Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 14(2):178–192. doi:10.1093/bib/bbs017 CrossRefPubMed

37.

Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP), Seattle, WA (URL: http://evs.gs.washington.edu/EVS/) [Aug. 2016 accessed].

38.

Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T et al (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536(7616):285–291. doi:10.1038/nature19057

39.

Adzhubei I, Schmidt S, Peshkin L, Ramensky V, Gerasimova A, Bork P et al (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248–249. doi:10.1038/nmeth0410-248 CrossRefPubMedPubMedCentral

40.

Schwarz J, Cooper D, Shuelke M, Seelow D (2014) MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11(4):361–362. doi:10.1038/nmeth.2890 CrossRefPubMed

41.

Kumar P, Henikoff S, Ng P (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4(8):1073–1082. doi:10.1038/nprot.2009.86 CrossRefPubMed

42.

Kircher M, Witten D, Jain P, O’Roak B, Cooper G, Shendure J (2014) A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46(3):310–315. doi:10.1038/ng.2892 CrossRefPubMedPubMedCentral

43.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424. doi:10.1038/gim.2015.30 CrossRefPubMedPubMedCentral

44.

Halliday D, Hutchinson S, Lonie L, Hurst J, Firth H, Handford P (2002) Twelve novel FBN1 mutations in Marfan syndrome and Marfan related phenotypes test the feasibility of FBN1 mutation testing in clinical practice. J Med Genet 39(8):589–593CrossRefPubMedPubMedCentral

45.

van de Luijtgaarden K, Heijsman D, Maugeri A, Weiss M, Verhagen H, Ijpma A et al (2015) First genetic analysis of aneurysm genes in familial and sporadic abdominal aortic aneurysm. Hum Genet 134(8):881–893. doi:10.1007/s00439-015-1567-0 CrossRefPubMedPubMedCentral

46.

Harakalova M, van der Smagt J, de Kovel C, Van’t Slot R, Poot M, Nijman I et al (2013) Incomplete segregation of MYH11 variants with thoracic aortic aneurysms and dissections and patent ductus arteriosus. Eur J Hum Genet 21(5):487–493. doi:10.1038/ejhg.2012.206 CrossRefPubMed

47.

Imai Y, Morita H, Takeda N, Miya F, Hyodo H, Fujita D et al (2015) A deletion mutation in myosin heavy chain 11 causing familial thoracic aortic dissection in two Japanese pedigrees. Int J Cardiol 195:290–292. doi:10.1016/j.ijcard.2015.05.178 CrossRefPubMed

48.

Meder B, Haas J, Keller A, Heid C, Just S, Borries A et al (2011) Targeted next-generation sequencing for the molecular genetic diagnostics of cardiomyopathies. Circ Cardiovasc Genet 4(2):110–122. doi:10.1161/CIRCGENETICS.110.958322 CrossRefPubMed

49.

Hertz C, Christiansen S, Ferrero-Miliani L, Fordyce S, Dahl M, Holst A et al (2015) Next-generation sequencing of 34 genes in sudden unexplained death victims in forensics and in patients with channelopathic cardiac diseases. Int J Legal Med 129(4):793–800. doi:10.1007/s00414-014-1105-y CrossRefPubMed

50.

Pua C, Bhalshankar J, Miao K, Walsh R, John S, Lim S et al (2016) Development of a comprehensive sequencing assay for inherited cardiac condition genes. J Cardiovasc Transl Res 9(1):3–11. doi:10.1007/s12265-016-9673-5 CrossRefPubMedPubMedCentral

Titel: Postmortem genetic testing should be recommended in sudden cardiac death cases due to thoracic aortic dissection
verfasst von: Marina Gago-Díaz
Eva Ramos-Luis
Silvia Zoppis
Esther Zorio
Pilar Molina
Aitana Braza-Boïls
Juan Giner
Beatriz Sobrino
Jorge Amigo
Alejandro Blanco-Verea
Ángel Carracedo
María Brion
Publikationsdatum: 08.04.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: International Journal of Legal Medicine / Ausgabe 5/2017
Print ISSN: 0937-9827
Elektronische ISSN: 1437-1596
DOI: https://doi.org/10.1007/s00414-017-1583-9

Springer Medizin

Postmortem genetic testing should be recommended in sudden cardiac death cases due to thoracic aortic dissection

Abstract

Background

Materials and methods

Results

Conclusions

Neu im Fachgebiet Rechtsmedizin

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie

Springer Medizin

Abstract

Background

Materials and methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2017

Introduction of sample tubes with sodium azide as a preservative for ethyl glucuronide in urine

DNA persistence of bite marks on food and its relevance for STR typing

A comprehensive Y-STR portrait of Yousafzai’s population

Temperature-corrected post-mortem 1.5 T MRI quantification of non-pathologic upper abdominal organs

Wound morphology in contact shots from blank cartridge handguns: a study on composite models

Estimation of stature from femur length measured using computed tomography after the analysis of three-dimensional characteristics of femur bone in Korean cadavers

Neu im Fachgebiet Rechtsmedizin

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie